Skip to main content
Log in

The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain

  • Short Communication
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

We have used quantitative autoradiography to further examine two previously described binding sites for [3H]-CGS 21680 in cortical regions and in striatum, respectively. The striatal binding sites largely represent classical adenosine A2A receptors whereas the cortical sites show characteristics that differ from those of recognised adenosine receptors. A recently developed non-xanthine A2A receptor antagonist SCH 58261 displaced the binding of [3H]-CGS 21680 from the A2A receptors in striatum with an estimated Ki value of 2.4 nM, but was more than 1000-fold less potent in displacing its binding from cortex. Conversely, the adenosine analogue 2-chloro-NECA was found to be some 10 times more potent in displacing CGS 21680 from the cortical binding sites than from A2A receptors. The results provide additional evidence that CGS 21680 binds not only to classical A2A receptors, but also to sites that differ from defined adenosine receptors. They also suggest that effects of CGS 21680 observed in the presence of SCH 58261 might reveal the functional significance (if any) of these sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Baraldi PG, Manfredini S, Simoni D, Zappaterra L, Zocchi C, Dionisotti S, Ongini E (1994) Synthesis of new pyrazolo [4–3-e]-1,2,4-triazolo[1,5-c] pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4 triazolo [1,5-c]pyrimidine displaying potent and selective activity as A2A adenosine receptor antagonists. Bioorg Med Chem Lett 4:2539–2544

    Google Scholar 

  • Cunha RA, Johansson B, Constantino MD, Sebastião AM, Fredholm BB (1996) Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H]CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn-Schmiedeberg's Arch Pharmacol 353:261–271

    Google Scholar 

  • Fein T, Schulze E, Bar J, Schwabe U (1994) Purification and characterization of an adenotin-like adenosine binding protein from human platelets. Naunyn-Schmiedeberg's Arch Pharmacol 349:374–380

    Google Scholar 

  • Ferro S, Rubio A, Fuxe K (1991) Stimulation of adenosine A2 receptors induces catalepsy. Neurosci Lett 130:162–164

    Google Scholar 

  • Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143–156

    Google Scholar 

  • Hutchison AJ, Webb RL, Oei HH, Ghai GR, Zimmerman MB, Williams M (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47–55

    Google Scholar 

  • Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M (1989) 3H-CGS 21680, a selective A2 adenosine receptor agonist, directly labels A2 receptors in rat brain. J Pharmacol Exp Ther 251:888–893

    Google Scholar 

  • Johansson B, Fredholm BB (1995) Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology 34:393–403

    Google Scholar 

  • Johansson B, Georgiev V, Parkinson FE, Fredholm BB (1993) The binding of the adenosine A2 selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur J Pharmacol, Mol Pharmacol Sect 247:103–110

    Google Scholar 

  • Morelli M, Fenu S, Pinna A, Di Chiara G (1994) Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Pharmacol 251:21–25

    Google Scholar 

  • Ongini E, Fredholm BB (1996) Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci (in press)

  • Parkinson FE, Fredholm BB (1990) Autoradiographic evidence for G-protein coupled A2-receptors in rat neostriatum using [3H]-CGS 21680 as a ligand. Naunyn-Schmiedeberg's Arch Pharmacol 342:85–89

    Google Scholar 

  • Paxinos G, Watson W (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, London

    Google Scholar 

  • Wan W, Sutherland GR, Geiger JD (1990) Binding of the adenosine A2 receptor ligand [3H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. J Neurochem 55:1763–1771

    Google Scholar 

  • Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, Dionisotti S (1996) The non-xanthine heterocyclic compound, SCH 58261, is a new potent and selective A2A adenosine receptor antagonist. J Pharmacol Exp Ther 276:398–404

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindstrom, K., Ongini, E. & Fredhohn, B.B. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 354, 539–541 (1996). https://doi.org/10.1007/BF00168448

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00168448

Key words

Navigation